Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Astellas, Astrazeneca, Caladrius, Celltrion, Chromadex, CSL Behring, Eli Lilly, Emergent Biosolutions, Gilead Sciences, Glaxosmithkline, Grifols, Napajen, Noxopharm, Redhill Biopharma, Rigel, Seagen, Takeda, University of Oxford, Vir, Zai Lab.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apellis, Bold, Caladrius, CSL, Emergent, Gilead, Grifols, Pfizer, Rigel, Sobi, Sumitomo Dainippon, Takeda, University of Oxford.